Home Finance specialist What can $ 2.1 billion do for infection control in the aftermath of COVID-19?

What can $ 2.1 billion do for infection control in the aftermath of COVID-19?



WALTHAM, Mass .– (COMMERCIAL THREAD) – Wolters Kluwer Health

What: The Center for Disease Control and Prevention (CDC) announced on Friday that the agency will invest $ 2.1 billion to improve infection prevention and control activities in the public health and healthcare sectors in the United States. United.

Why: The investment will enable the United States to improve public health and the quality of health care, including by addressing inequalities in health care. According to CDC Announcement the funds: “… will help healthcare workers to more effectively prevent infections in healthcare facilities, support a rapid response to detect and contain infectious organisms, improve laboratory capacity and engage in innovation aimed at to combat the threats of infectious diseases. Infection prevention improvements will span the continuum of health care, including 6,000 hospitals, 15,400 nursing homes and other long-term care facilities, 7,900 dialysis clinics and 4,700 day surgery centers, and will expand to other outpatient care facilities.

Who: Mackenzie weise, MPH, CIC, Clinical Infection Prevention Program Manager for Clinical Surveillance and Compliance, Wolters Kluwer, is a qualified epidemiologist with over 12 years of experience in the areas of infectious disease, data analysis and health informatics. She believes the multi-billion dollar investment the White House is making will have significant impacts as follows:

“The COVID-19 pandemic has highlighted a significant number of issues related to the state of infection prevention and control (IPC) in the United States. from large public spaces to the bedside. Key elements of this initiative include:

  • $ 500 million will be allocated to jurisdictional health services in October 2021 to fund the staffing, training and deployment of specialist strike teams to assist skilled nursing facilities, nursing homes and other health facilities. long-term care in the fight against COVID-19 to help protect some of our most vulnerable populations.
  • $ 385 million will be allocated to jurisdictional health services in October 2021 to strengthen five critical areas, including 1) strengthening state capacity to prevent, detect and contain infectious disease threats in health facilities, 2 ) laboratory capacity for health care, 3) CDC’s national frontline project a training collaboration for infection control in health care, 4) health care associated infection tracking system CDC’s National Health Care Safety Network (NHSN), as well as 5) antibiotic stewardship efforts to address issues related to antibiotic use.
  • $ 880 million will be used over several years to help health partners, academic institutions and other nonprofit partners develop new prevention interventions and capacities for infection prevention and control training, data collection and technical assistance.

How? ‘Or’ What: Contact Ashley Beine at [email protected] to schedule an interview with Mackenzie Weise. Journalists can also publish the above quote with appropriate attribution.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for clinicians, nurses, accountants, lawyers and the tax, finance, audit, risk, compliance and regulation. We help our clients make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer achieved 2020 annual sales of 4.6 billion euros. The group serves customers in more than 180 countries, maintains operations in more than 40 countries and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides reliable clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision making and outcomes in healthcare. We support clinical efficacy, learning and research, clinical monitoring and compliance, and data solutions. For more information on our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information visit www.wolterskluwer.com, Follow us on Twitter, Facebook, LinkedIn, and Youtube.



Please enter your comment!
Please enter your name here